Cytokinetics (CYTK) Debt Ratio (2010 - 2026)

Cytokinetics (CYTK) has reported Debt Ratio for 15 consecutive years, with 0.23 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt Ratio rose 176.09% year-over-year to 0.23; the TTM figure through Mar 2026 stood at 0.23 (up 176.09% YoY), while the FY2025 annual figure was 0.2, up 170.13% from the prior year.
• Debt Ratio improved to 0.23 in Q1 2026 per CYTK's latest filing, from 0.2 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.23 in Q1 2026 and bottomed at 0.06 in Q3 2022.
• Historically, Debt Ratio has averaged 0.1 across 5 years, with a median of 0.08 in 2022.
• Annual changes were most pronounced in 2024 — Debt Ratio decreased 14.54% — and 2026, when it surged 176.09%.
• Cytokinetics' Debt Ratio stood at 0.06 in 2022, then jumped by 30.13% to 0.08 in 2023, then fell by 10.02% to 0.07 in 2024, then jumped by 170.13% to 0.2 in 2025, then climbed by 13.59% to 0.23 in 2026.
• Business Quant data shows CYTK's Debt Ratio at 0.23 in Q1 2026, 0.2 in Q4 2025, and 0.12 in Q3 2025.